958
Views
59
CrossRef citations to date
0
Altmetric
Review

Anticancer drug discovery using multicellular tumor spheroid models

, , , &
Pages 289-301 | Received 01 Oct 2018, Accepted 11 Jan 2019, Published online: 28 Jan 2019

References

  • Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108.
  • Drost J, Clevers H. Organoids in cancer research. Nat Rev Cancer. 2018;18:407–418.
  • Hutchinson L, Kirk R. High drug attrition rates-where are we going wrong? Nat Rev Clin Oncol. 2011;8:189–190.
  • Ocana A, Pandiella A, Siu LL, et al. Preclinical development of molecular-targeted agents for cancer. Nat Rev Clin Oncol. 2010;8:200–209.
  • Sant S, Johnston PA. The production of 3D tumor spheroids for cancer drug discovery. Drug Discov Today Technol. 2017;23:27–36.
  • Arrowsmith J, Miller P. Trial watch: phase II and phase III attrition rates 2011–2012. Nat Rev Drug Discov. 2013;12:569.
  • Ronaldson-Bouchard K, Vunjak-Novakovic G. Organs-on-a-chip:a fast track for engineered human tissues in drug development. Cell Stem Cell. 2018;22:310–324.
  • Baker BM, Chen CS. Deconstructing the third dimension: how 3D culture microenvironments alter cellular cues. J Cell Sci. 2012;125:3015–3024.
  • Friedrich J, Seidel C, Ebner R, et al. Spheroid-based drug screen: considerations and practical approach. Nat Protoc. 2009;4:309–324.
  • Zanoni M, Piccinini F, Arienti C, et al. 3D tumor spheroid models for in vitro therapeutic screening: a systematic approach to enhance the biological relevance of data obtained. Sci Rep. 2016;6:19103.
  • Lee GY, Kenny PA, Lee EH, et al. Three-dimensional culture models of normal and malignant breast epithelial cells. Nat Methods. 2007;4:359–365.
  • Thoma CR, Zimmermann M, Agarkova I, et al. 3D cell culture systems modeling tumor growth determinants in cancer target discovery. Adv Drug Deliv Rev. 2014;69–70:29–41.
  • Wartenberg M, Ling FC, Müschen M, et al. Regulation of the multidrug resistance transporter P-glycoprotein in multicellular tumor spheroids by hypoxia-inducible factor (HIF-1) and reactive oxygen species. FASEB J. 2003;17:503–505.
  • Kimlin LC, Casagrande G, Virador VM. In vitro three-dimensional (3D) models in cancer research: an update. Mol Carcinog. 2013;52:167–182.
  • Minchinton AI, Tannock IF. Drug penetration in solid tumours. Nat Rev Cancer. 2006;6:583–592.
  • Yamada KM, Cukierman E. Modeling tissue morphogenesis and cancer in 3D. Cell. 2007;130:601–610.
  • Edmondson R, Broglie JJ, Adcock AF, et al. Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors. Assay Drug Dev Technol. 2014;12:207–218.
  • Elsdale T, Bard J. Cellular interactions in mass cultures of human diploid fibroblasts. Nature. 1972;236:152–155.
  • Pradhan S, Hassani I, Clary JM, et al. Polymeric biomaterials for in vitro cancer tissue engineering and drug testing applications. Tissue Eng Part B Rev. 2016;22:470–484.
  • Santo VE, Rebelo SP, Estrada MF, et al. Drug screening in 3D in vitro tumor models: overcoming current pitfalls of efficacy read-outs. Biotechnol J. 2017;12(1).  doi: 10.1002/biot.201600505. Epub 2016 Dec 14.
  • Langhans SA. Three-dimensional in vitro cell culture models in drug discovery and drug repositioning. Front Pharmacol. 2018;9:6.
  • Zhang YS, Khademhosseini A. Advances in engineering hydrogels. Science. 2017;356(6337):pii:eaaf3627.
  • Weber LM, Hayda KN, Haskins K, et al. The effects of cell-matrix interactions on encapsulated beta-cell function within hydrogels functionalized with matrix-derived adhesive peptides. Biomaterials. 2007;28:3004–3011.
  • Yao J, Tao SL, Young MJ. Synthetic polymer scaffolds for stem cell transplantation in retinal tissue engineering. Polymers. 2011;3:899–914.
  • Roudsari LC, Jeffs SE, Witt AS, et al. A 3D poly(ethylene glycol)-based tumor angiogenesis model to study the influence of vascular cells on lung tumor cell behavior. Sci Rep. 2016;6:32726.
  • Colvin KM, Gordon VD, Murakami K, et al. The pel polysaccharide can serve a structural and protective role in the biofilm matrix of pseudomonas aeruginosa. PLoS Pathog. 2011;7:e1001264.
  • Liaw CY, Ji S, Guvendiren M. Engineering 3D hydrogels for personalized in vitro human tissue models. Adv Healthc Mater. 2018;7(4). doi: 10.1002/adhm.201701165. Epub 2018 Jan 18.
  • Shelke NB, James R, Laurencin CT, et al. Polysaccharide biomaterials for drug delivery and regenerative engineering. Polym Adv Technol. 2014;25:448–460.
  • Griffith LG, Swartz MA. Capturing complex 3D tissue physiology in vitro. Nat Rev Mol Cell Biol. 2006;7:211–224.
  • Worthington P, Pochan DJ, Langhans SA. Peptide hydrogels – versatile matrices for 3D cell culture in cancer medicine. Front Oncol. 2015;20,5:92.
  • Branco MC, Sigano DM, Schneider JP. Materials from peptide assembly: towards the treatment of cancer and transmittable disease. Curr Opin Chem Biol. 2011;15:427–434.
  • Knight E, Murray B, Carnachan R, et al. Alvetex®: polystyrene scaffold technology for routine three dimensional cell culture. Methods Mol Biol. 2011;695:323–340.
  • Ryan SL, Baird AM, Vaz G, et al. Drug discovery approaches utilizing three-dimensional cell culture. Assay Drug Dev Technol. 2016;14:19–28.
  • Hughes CS, Postovit LM, Lajoie GA. Matrigel: a complex protein mixture required for optimal growth of cell culture. Proteomics. 2010;10:1886–1890.
  • Egeblad M, Rasch MG, Weaver VM. Dynamic interplay between the collagen scaffold and tumor evolution. Curr Opin Cell Biol. 2010;22:697–706.
  • Kalluri R. Basement membranes: structure, assembly and role in tumour angiogenesis. Nat Rev Cancer. 2003;3:422–433.
  • Paszek MJ, Zahir N, Johnson KR, et al. Tensional homeostasis and the malignant phenotype. Cancer Cell. 2005;8:241–254.
  • Sethi T, Rintoul RC, Moore SM, et al. Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo. Nat Med. 1999;5:662–668.
  • Heldin CH, Rubin K, Pietras K, et al. High interstitial fluid pressure - an obstacle in cancer therapy. Nat Rev Cancer. 2004;4:806–813.
  • Reynolds DS, Tevis KM, Blessing WA, et al. Breast cancer spheroids reveal a differential cancer stem cell response to chemotherapeutic treatment. Sci Rep. 2017;7:10382.
  • Chambers KF, Mosaad EM, Russell PJ, et al. 3D cultures of prostate cancer cells cultured in a novel high-throughput culture platform are more resistant to chemotherapeutics compared to cells cultured in monolayer. PLoS One. 2014;9:e111029.
  • Ward JP, King J. Mathematical modelling of avascular-tumour growth. IMA J Math Appl Med Biol. 1997;14:39–69.
  • Costa EC, Moreira AF, de Melo-Diogo D, et al. 3D tumor spheroids: an overview on the tools and techniques used for their analysis. Biotechnol Adv. 2016;34:1427–1441.
  • Vinci M, Gowan S, Boxall F, et al. Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation. BMC Biol. 2012;10:29.
  • Tesei A, Sarnelli A, Arienti C, et al. In vitro irradiation system for radiobiological experiments. Radiat Oncol. 2013;8:257.
  • Chan HF, Zhang Y, Ho YP, et al. Rapid formation of multicellular spheroids in double-emulsion droplets with controllable microenvironment. Sci Rep. 2013;3:3462.
  • McMillin DW, Negri JM, Mitsiades CS. The role of tumour-stromal interactions in modifying drug response: challenges and opportunities. Nat Rev Drug Discov. 2013;12:217–228.
  • Pickl M, Ries CH. Comparison of 3D and 2D tumor models reveals enhanced HER2 activation in 3D associated with an increased response to trastuzumab. Oncogene. 2009;28:461–468.
  • Muranen T, Selfors LM, Worster DT, et al. Inhibition of PI3K/mTOR leads to adaptive resistance in matrix-attached cancer cells. Cancer Cell. 2012;21:227–239.
  • Candido S, Abrams SL, Steelman LS, et al. Roles of NGAL and MMP-9 in the tumor microenvironment and sensitivity to targeted therapy. Biochim Biophys Acta. 2016;1863:438–448.
  • Warburg O, Wind F, Negelein E. The metabolism of tumors in the body. J Gen Physiol. 1927;8:519–530.
  • Shi Q, Le X, Wang B, et al. Regulation of vascular endothelial growth factor expression by acidosis in human cancer cells. Oncogene. 2001;20:3751–3756.
  • Huber V, Camisaschi C, Berzi A, et al. Cancer acidity: an ultimate frontier of tumor immune escape and a novel target of immunomodulation. Semin Cancer Biol. 2017;43:74–89.
  • Cowan DS, Tannock IF. Factors that influence the penetration of methotrexate through solid tissue. Int J Cancer. 2001;91:120–125.
  • Mitchison TJ. The proliferation rate paradox in antimitotic chemotherapy. Mol Biol Cell. 2012;23:1–6.
  • Wigerup C, Påhlman S, Bexell D. Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer. Pharmacol Ther. 2016;164:152–169.
  • Sonveaux P. ROS and radiotherapy: more we care. Oncotarget. 2017;8:35482–35483.
  • Nunes AS, Barros AS, Costa EC, et al. 3D tumor spheroids as in vitro models to mimic in vivo human solid tumors resistance to therapeutic drugs. Biotechnol Bioeng. 2019;116:206–226.
  • Doublier S, Belisario DC, Polimeni M, et al. HIF-1 activation induces doxorubicin resistance in MCF7 3-D spheroids via P-glycoprotein expression: a potential model of the chemo-resistance of invasive micropapillary carcinoma of the breast. BMC Cancer. 2012;12:4.
  • Rodríguez CE, Moverer LM, Reidel SI, et al. Cytotoxic effect of trastuzumab on macrophage-infiltrated human mammary tumor spheroids. Cancer Res. 2012;72:2881.
  • Lao Z, Kelly CJ, Yang XY, et al. Improved methods to generate spheroid cultures from tumor cells, tumor cells & fibroblasts or tumor-fragments: microenvironment, microvesicles and MiRNA. PLoS One. 2015;10:e0133895.
  • Lamichhane SP, Arya N, Kohler E, et al. Recapitulating epithelial tumor microenvironment in vitro using three dimensional tri-culture of human epithelial, endothelial, and mesenchymal cells. BMC Cancer. 2016;16:581.
  • McMillin DW, Delmore J, Weisberg E, et al. Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity. Nat Med. 2010;16:483–489.
  • Clevers H. Modeling development and disease with organoids. Cell. 2016;165:1586–1597.
  • Sachs N, de Ligt J, Kopper O, et al. A living biobank of breast cancer organoids captures disease heterogeneity. Cell. 2018;172:373–386.
  • Fujii M, Shimokawa M, Date S, et al. A colorectal tumor organoid library demonstrates progressive loss of niche factor requirements during tumorigenesis. Cell Stem Cell. 2016;18:827–838.
  • Huang L, Holtzinger A, Jagan I, et al. Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell- and patient-derived tumor organoids. Nat Med. 2015;21:1364–1371.
  • Artegiani B, Clevers H. Use and application of 3D-organoid technology. Hum Mol Genet. 2018;27:99–107.
  • Broutier L, Mastrogiovanni G, Verstegen MMA, et al. Human primary liver cancer-derived organoid cultures for disease modeling and drug screening. Nat Med. 2017;23:1424–1435.
  • Workman MJ, Mahe MM, Trisno S, et al. Engineered human pluripotent-stem-cell-derived intestinal tissues with a functional enteric nervous system. Nat Med. 2017;23:49–59.
  • Seino T, Kawasaki S, Shimokawa M, et al. Human pancreatic tumor organoids reveal loss of stem cell niche factor dependence during disease progression. Cell Stem Cell. 2018;22:454–467.
  • Gjorevski N, Sachs N, Manfrin A, et al. Designer matrices for intestinal stem cell and organoid culture. Nature. 2016;539:560–564.
  • Tüysüz N, van Bloois L, van Den Brink S, et al. Lipid-mediated Wnt protein stabilization enables serum-free culture of human organ stem cells. Nat Commun. 2017;8:14578.
  • Hubert CG, Rivera M, Spangler LC, et al. A three-dimensional organoid culture system derived from human glioblastomas recapitulates the hypoxic gradients and cancer stem cell heterogeneity of tumors found in vivo. Cancer Res. 2016;76:2465–2477.
  • Kelm JM, Timmins NE, Brown CJ, et al. Method for generation of homogeneous multicellular tumor spheroids applicable to a wide variety of cell types. Biotechnol Bioeng. 2003;83:173–180.
  • Drewitz M, Helbling M, Fried N, et al. Towards automated production and drug sensitivity testing using scaffold-free spherical tumor microtissues. Biotechnol J. 2011;6:1488–1496.
  • Lin RZ, Chang HY. Recent advances in three-dimensional multicellular spheroid culture for biomedical research. Biotechnol J. 2008;3:1172–1184.
  • Hamilton GA, Westmorel C, George AE. Effects of medium composition on the morphology and function of rat hepatocytes cultured as spheroids and monolayers. In Vitro Cell Dev Biol Anim. 2001;37:656–667.
  • Souza GR, Molina JR, Raphael RM, et al. Three-dimensional tissue culture based on magnetic cell levitation. Nat Nanotechnol. 2010;5:291–296.
  • Timm DM, Chen J, Sing D, et al. A high-throughput three-dimensional cell migration assay for toxicity screening with mobile device-based macroscopic image analysis. Sci Rep. 2013;3:3000.
  • Tseng H, Gage JA, Shen T, et al. A spheroid toxicity assay using magnetic 3D bioprinting and real-time mobile device based imaging. Sci Rep. 2015;5:13987.
  • Johnstone B, Hering TM, Caplan AI, et al. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res. 1998;238:265–272.
  • Sutherland RM, McCredie JA, Inch WR. Growth of multicell spheroids in tissue culture as a model of nodular carcinomas. J Natl Cancer Inst. 1971;46:113–120.
  • Ingram M, Techy GB, Saroufeem R, et al. Three-dimensional growth patterns of various human tumor cell lines in simulated microgravity of a NASA bioreactor. In Vitro Cell Dev Biol Anim. 1997;33:459–466.
  • Unsworth BR, Lelkes PI. Growing tissues in microgravity. Nat Med. 1998;4:901–907.
  • Carragher N, Piccinini F, Tesei A, et al. Concerns, challenges and promises of high-content analysis of 3D cellular models. Nat Rev Drug Discov. 2018;17:606.
  • Ho WY, Yeap SK, Ho CL, et al. Development of multicellular tumor spheroid (MCTS) culture from breast cancer cell and a high throughput screening method using the MTT assay. PLoS One. 2012;7:e44640.
  • Eilenberger C, Kratz SRA, Rothbauer M, et al. Optimized alamarBlue assay protocol for drug dose-response determination of 3D tumor spheroids. MethodsX. 2018;5:781–787.
  • Pignatta S, Orienti I, Falconi M, et al. Albumin nanocapsules containing fenretinide: pre-clinical evaluation of cytotoxic activity in experimental models of human non-small cell lung cancer. Nanomedicine. 2015;11:263–273.
  • Patra B, Peng CC, Liao WH, et al. Drug testing and flow cytometry analysis on a large number of uniform sized tumor spheroids using a microfluidic device. Sci Rep. 2016;6:21061.
  • Grässer U, Bubel M, Sossong D, et al. Dissociation of mono- and co-culture spheroids into single cells for subsequent flow cytometric analysis. Ann Anat. 2018;216:1–8.
  • Chen X, Wei B, Han X, et al. LGR5 is required for the maintenance of spheroid-derived colon cancer stem cells. Int J Mol Med. 2014;34:35–42.
  • Chen MW, Yang ST, Chien MH, et al. The STAT3-miRNA-92-Wnt signaling pathway regulates spheroid formation and malignant progression in ovarian cancer. Cancer Res. 2017;77:1955–1967.
  • Barbone D, Van Dam L, Follo C, et al. Analysis of gene expression in 3D spheroids highlights a survival role for ASS1 in mesothelioma. PLoS One. 2016;11:e0150044.
  • Celli JP, Rizvi I, Blanden AR, et al. An imaging-based platform for high-content, quantitative evaluation of therapeutic response in 3D tumour models. Sci Rep. 2014;4:3751.
  • Piccinini F, Tesei A, Arienti C, et al. Cancer multicellular spheroids: volume assessment from a single 2D projection. Comput Methods Programs Biomed. 2015;118:95–106.
  • le Roux L, Volgin A, Maxwell D, et al. Optimizing imaging of three-dimensional multicellular tumor spheroids with fluorescent reporter proteins using confocal microscopy. Mol Imaging. 2008;7:214–221.
  • Vidi PA, Bissell MJ, Lelièvre SA. Three-dimensional culture of human breast epithelial cells: the how and the why. Methods Mol Biol. 2013;945:193–219.
  • Seo J, Choe M, Kim SY. Clearing and labeling techniques for large-scale biological tissues. Mol Cells. 2016;39:439–446.
  • Huisken J, Swoger J, Del Bene F, et al. Optical sectioning deep inside live embryos by selective plane illumination microscopy. Science. 2004;305:1007–1009.
  • Cella Zanacchi F, Lavagnino Z, Perrone Donnorso M, et al. Live-cell 3D super-resolution imaging in thick biological samples. Nat Methods. 2011;8:1047–1049.
  • Hwang YJ, Kolettis N, Yang M, et al. Multiphoton imaging of actin filament formation and mitochondrial energetics of human ACBT gliomas. Photochem Photobiol. 2011;87:408–417.
  • Rios AC, Clevers H. Imaging organoids: a bright future ahead. Nat Methods. 2018;15:24–26.
  • Chen BC, Legant WR, Wang K, et al. Lattice light-sheet microscopy: imaging molecules to embryos at high spatiotemporal resolution. Science. 2014;346:1257998.
  • Huang K, Ma H, Liu J, et al. Size-dependent localization and penetration of ultrasmall gold nanoparticles in cancer cells, multicellular spheroids, and tumors in vivo. ACS Nano. 2012;6:4483–4493.
  • Costa EC, Gaspar VM, Coutinho P, et al. Optimization of liquid overlay technique to formulate heterogenic 3D co-cultures models. Biotechnol Bioeng. 2014;111:1672–1685.
  • Uroukov IS, Patton D. Optimizing environmental scanning electron microscopy of spheroidal reaggregated neuronal cultures. Microsc Res Tech. 2008;71:792–801.
  • Conger AD, Ziskin MC. Growth of mammalian multicellular tumor spheroids. Cancer Res. 1983;43:556–560.
  • Freyer JP. Role of necrosis in regulating the growth saturation of multicellular spheroids. Cancer Res. 1988;48:2432–2439.
  • Mehta G, Hsiao AY, Ingram M, et al. Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy. J Control Release. 2012;164:192–204.
  • Nath S, Devi GR. Three-dimensional culture systems in cancer research: focus on tumor spheroid model. Pharmacol Ther. 2016;163:94–108.
  • Kessel S, Cribbes S, Déry O, et al. High-throughput 3D tumor spheroid screening method for cancer drug discovery using celigo image cytometry. SLAS Technol. 2017;22:454–465.
  • Kondo J, Ekawa T, Endo H, et al. High-throughput screening in colorectal cancer tissue-originated spheroids. Cancer Sci. 2019;110:345–355.
  • Lee JM, Park DY, Yang L, et al. Generation of uniform-sized multicellular tumor spheroids using hydrogel microwells for advanced drug screening. Sci Rep. 2018;8:17145.
  • Quereda V, Hou S, Madoux F, et al. A cytotoxic three-dimensional-spheroid, high-throughput assay using patient-derived glioma stem cells. SLAS Discov. 2018;23:842–849.
  • Neal JT, Li X, Zhu J, et al. Organoid modeling of the tumor immune microenvironment. Cell. 2018;175:1972–1988.
  • Chen F, Tillberg PW, Boyden ES. Optical imaging. Expansion microscopy. Science. 2015;347:543–548.
  • Karimi M, Bahrami S, Mirshekari H, et al. Microfluidic systems for stem cell-based neural tissue engineering. Lab Chip. 2016;16:2551–2571.
  • Mohammadi MH, Heidary Araghi B, Beydaghi V, et al. Skin diseases modeling using combined tissue engineering and microfluidic technologies. Adv Healthc Mater. 2016;5:2459–2480.
  • Huh D, Hamilton GA, Ingber DE. From 3D cell culture to organs-on-chips. Trends Cell Biol. 2011;21:745–754.
  • Sabhachandani P, Motwani V, Cohen N, et al. Generation and functional assessment of 3D multicellular spheroids in droplet based microfluidics platform. Lab Chip. 2016;16:497–505.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.